JPMorgan Chase & Co. Invests $105,000 in Adagio Medical Holdings, Inc. (NASDAQ:ADGM)

JPMorgan Chase & Co. acquired a new stake in Adagio Medical Holdings, Inc. (NASDAQ:ADGM) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 100,000 shares of the company’s stock, valued at approximately $105,000. JPMorgan Chase & Co. owned approximately 0.65% of Adagio Medical as of its most recent filing with the SEC.

Adagio Medical Price Performance

Adagio Medical stock opened at $1.28 on Tuesday. The firm has a fifty day simple moving average of $1.02 and a two-hundred day simple moving average of $1.50. Adagio Medical Holdings, Inc. has a twelve month low of $0.63 and a twelve month high of $9.34. The company has a debt-to-equity ratio of 0.18, a current ratio of 4.42 and a quick ratio of 3.90.

Adagio Medical Company Profile

Adagio Medical Holdings, Inc, a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia.